(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

AYANDA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

AYANDA

ST13

US500000079206513

Classe

5, 40

Pedido

79206513

Registro

5415114

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

37

Atualização mais recente

11/10/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 40

Data de depósito

23/12/2016

Data de registro

06/03/2018

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

20/09/2024

Última transação

11/10/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

98

Localização do titular

DE

Examinador

EVANKO,PATRICIA MALESARDI

Unidade examinadora

N10

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Sirio Pharma Germany GmbH
Ayanda GmbH
AYANDA GmbH & Co. KG

Representantes

Stewart J. Bellus Collard and Roe

Classificação técnica

Classes Nice

Classe 5Classe 40

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculoskeletal systemthe genitourinary systemfor the treatment of inflammatory disordersfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disordersfor the treatment of viralendocrinemusculoskeletalcardiopulmonarygenitourinarysexual dysfunctionhepatologicalneurologicalgastrointestinalhormonalpsychiatric and immune system related diseases and disordersfor the treatment of diabetesanti- infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccinesnot including birth-control productsproducts for the treatment of endometriosishormonal preparations; medical and veterinary preparations and articlesnutritional supplementsnot including contraceptivesproducts for treating endometriosishormone preparations; capsules sold empty for pharmaceuticals; capsules sold empty for nutritional supplements; dietetic food and substancesbeverages and in the form of capsulesdrageestabletsadapted for medical or veterinary use; food for babies; nutritional supplements; dietetic preparationsdietetic sugar for medical usedietetic foods and beverages for medical usefor treating vitamin deficiency; nutritional supplements in the form of capsulesdrageestabletscapsules made from gelatin; sanitary preparations for medical purposes; disinfectants; preparations for destroying noxious animals; fungicidesherbicides

Classe 40

Processing of foodstuffs for use in manufacture; processing of raw materials for the manufacture of food and beverages; custom manufacture and assembly services for others of pharmaceuticalsfoodstuffs and raw materials; custom manufacture and assembly services of dietetic preparations and nutritional supplements; custom manufacture and assembly services of medical and veterinary preparations and articles; and rentalhire and leasing in connection with the aforesaidrental of machines for pharmaceuticalsprocessing foodstuffs and raw materials; and adviceconsultancy and information for the aforesaidincluded in the classproviding technical advice related to the manufacture of foodstuffs and pharmaceuticals

Publicações

Histórico de despachos e eventos da marca no USPTO.

37 publicações encontradas

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

10/10/2025

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

18/09/2025

INPC

INVALIDATION PROCESSED

18/09/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

20/05/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

21/03/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

06/12/2024

C71T

CANCELLED SECTION 71

20/09/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/03/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

24/08/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

13/07/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/06/2018

FIMP

FINAL DISPOSITION PROCESSED

12/06/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/06/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

06/03/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

19/12/2017

PUBO

PUBLISHED FOR OPPOSITION

19/12/2017

GPNX

NOTIFICATION PROCESSED BY IB

15/12/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

29/11/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

29/11/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

29/11/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

16/11/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

16/11/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/11/2017

ALIE

ASSIGNED TO LIE

14/11/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/11/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/11/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/11/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

24/08/2017

RFNP

REFUSAL PROCESSED BY IB

03/06/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

16/05/2017

RFRR

REFUSAL PROCESSED BY MPU

16/05/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/05/2017

MAFR

APPLICATION FILING RECEIPT MAILED

09/05/2017

CNRT

NON-FINAL ACTION WRITTEN

08/05/2017

DOCK

ASSIGNED TO EXAMINER

05/05/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/05/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/05/2017

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace AYANDA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.